BCG, Hippocratic AI Partner to Deploy Agentic AI in Biopharma, Medtech
BCG and Hippocratic AI Join Forces to Drive Real-World Generative AI Impact Across Biopharma and Medtech Boston Consulting Group (BCG) and Hippocratic AI today announced a global strategic collaboration designed to accelerate the adoption of responsible, real-world generative artificial intelligence…
Diorasis Therapeutics Names Richard A. Kresch, MD to Board of Directors
Appointment Strengthens Company’s Expertise in Translational Medicine and Commercial Strategy Diorasis Therapeutics, a biotechnology company based in Boston and focused on developing durable gene therapies for glaucoma and other ophthalmic disorders, has announced the appointment of Richard A. Kresch, MD,…
MUSC Health, Baxter Form Partnership to Transform Bedside Care
Collaboration focuses on improving bedside care delivery through clinical innovation and workflow optimization MUSC Health and Baxter International Inc. a global medtech leader, are entering into a multi-year strategic partnership that aims to enhance the high-quality and safe patient care…
Fresenius Medical Care Speeds Up EUR 415M Share Buyback Phase
Company advances the second tranche of its EUR 1 billion capital return program Fresenius Medical Care the world’s leading provider of products and services for individuals with renal disease, will accelerate its share buyback program and start the repurchase of…
Compass Pathways Announces Strategic Collaboration with Radial
Compass Pathways partners with Radial Health to inform scalable COMP360 psilocybin delivery models and patient experience innovation across U.S. psychiatry clinics. Compass Pathways Radial collaboration marks a calculated step in the company’s long-term effort to define how regulated psychedelic therapies…
Sinovac Receives Nasdaq Notice for Late Filing of 2025 Half-Year Report
Sinovac Receives Nasdaq Notification Regarding Late Filing of 2025 Half-Year Report Sinovac Biotech Ltd. a leading provider of biopharmaceutical products in China, today announced that it has received a notification letter dated January 2, 2026 (the “Notification Letter”) from Nasdaq…
Immunotherapy Drugs Market – Global Analysis 2025 with Revenue History and 2030 Forecast
ResearchAndMarkets.com has added the report “Immunotherapy Drugs: Global Markets” to its portfolio, providing an in-depth analysis of one of the fastest-growing segments in the pharmaceutical industry. The global immunotherapy drugs market is expected to grow from $260.7 billion in 2025…
Europe Image-Guided Drug Delivery Market Outlook, 2025–2035
ResearchAndMarkets.com has announced the addition of a new report titled “Europe Image-Guided Drug Delivery Market: Focus on Technology Type, Application, End User, and Country Analysis (2025–2035).” The report provides a comprehensive assessment of the rapidly evolving image-guided drug delivery (IGDD)…
Global AI Digital Pathology Market Outlook, 2025–2035
ResearchAndMarkets.com has announced the addition of a comprehensive new market intelligence report titled “AI-Based Digital Pathology Market: Industry Trends and Global Forecasts Through 2035.” The report delivers an in-depth evaluation of one of the fastest-evolving segments of healthcare diagnostics, highlighting…
Medcare UAE Treats First International SMA Patient Using Intrathecal Gene Therapy
Medcare Expands Access to Breakthrough Intrathecal Gene Therapy for Spinal Muscular Atrophy, Treats First International Older Patient Medcare Women & Children Hospital has reached a significant milestone in the treatment of Spinal Muscular Atrophy (SMA) by successfully administering a newly…
Vicarious Surgical Taps Partner to Streamline Software Operations
Vicarious Surgical Enters Strategic Software Engineering Partnership to Enhance Execution, Predictability, and Operational Efficiency Vicarious Surgical, a next-generation robotics technology company focused on transforming robotic surgery to improve patient outcomes and expand access to minimally invasive procedures, today announced that…
EU Veterinary Pharmacovigilance Introductory Training (Mar 2026)
Introductory EU Veterinary Drug Safety Course (Mar 2026) The “Introduction to Veterinary Pharmacovigilance Training Course (March 9–10, 2026)” has been added to the growing portfolio of professional training programs available through ResearchAndMarkets.com. This comprehensive two-day course is designed to deliver…